Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neovascular Age-related Macular Edema”

50 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 50 results

Testing effectiveness (Phase 2)Study completedNCT06176963
What this trial is testing

Evaluate the Usability of the SB11 PFS in Subjects With Wet AMD or Macular Oedema Secondary to RVO

Who this might be right for
Neovascular Age-related Macular DegenerationMacular EdemaRetinal Vein Occlusion
Samsung Bioepis Co., Ltd. 34
Not applicableStudy completedNCT04455399
What this trial is testing

Time Efficiency Comparison of Two IntraVitreal Injection Techniques

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion With Macular Edema+2 more
Peregrine Eye and Laser Institute 200
Not applicableStudy completedNCT04847895
What this trial is testing

Observation of Treatment Patterns With Lucentis® in Real-life Conditions in All Approved Indications

Who this might be right for
Neovascular (Wet) Age-related Macular Degeneration
Novartis Pharmaceuticals 5,500
Not applicableStudy completedNCT06769412
What this trial is testing

A Real-World Evidence Study for the Incidence of Retinal Vasculitis (RV) Among Adult Patients Receiving Aflibercept 2 mg in the United States (US)

Who this might be right for
Retinal Vasculitis
Regeneron Pharmaceuticals 550,000
Early research (Phase 1)Study completedNCT02867735
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Intravitreal LKA651 in Patients With Macular Edema

Who this might be right for
Macular EdemaDiabetic Macular EdemaNeovascular Age-related Macular Degeneration+1 more
Novartis Pharmaceuticals 28
Post-approval studies (Phase 4)UnknownNCT03056079
What this trial is testing

Cytokine and Visual Outcome Variations in Eyes Receiving Aflibercept

Who this might be right for
Age Related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion+1 more
Unity Health Toronto 168
Large-scale testing (Phase 3)Study completedNCT05569148
What this trial is testing

A Study in Patients With Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema to Evaluate the Safety of the Faricimab Prefilled Syringe

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular Edema
Hoffmann-La Roche 35
Large-scale testing (Phase 3)Study completedNCT04516278
What this trial is testing

A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders

Who this might be right for
Age-related Macular DegenerationNeovascular Age-related Macular DegenerationWet Macular Degeneration+2 more
Outlook Therapeutics, Inc. 195
Not applicableLooking for participantsNCT06680817
What this trial is testing

A Real-World Study to Gain Clinical Insights Into Faricimab (FaReal Study)

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular Edema
Hoffmann-La Roche 850
Not applicableLooking for participantsNCT06439576
What this trial is testing

Real World Evidence in China: Faricimab Use in Diabetic Macular Edema, Retinal Vein Occlusion, and Neovascular Age-Related Macular Degeneration (The Farseeing Study)

Who this might be right for
Diabetic Macular EdemaNeovascular Age-related Macular DegenerationRetinal Vein Occlusion
Hoffmann-La Roche 1,000
Not applicableStudy completedNCT02420132
What this trial is testing

Study to Evaluate Home Vision Testing in Participants Who Receive Ranibizumab (Lucentis®)

Who this might be right for
Macular EdemaMacular Degeneration
Hoffmann-La Roche 47
Large-scale testing (Phase 3)Study completedNCT04264819
What this trial is testing

Study of Brolucizumab in Adult Patients With Suboptimal Anatomically Controlled Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Novartis Pharmaceuticals 295
Not applicableStudy completedNCT06723288
What this trial is testing

A Study Conducted to Evaluate the Conjunctiva and Tenon's Capsule Status of Healthy Subjects and in Participants With Neovascular Age-related Macular Degeneration (nAMD)/Diabetic Macular Edema (DME)

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular Edema
Hoffmann-La Roche 736
Not applicableStudy completedNCT04543331
What this trial is testing

Observational Study to Evaluate Fluid Resolution and Effectiveness in Patients Receiving Beovu in Neovascular Age-related Macular Degeneration and Visual Impairment Due to Diabetic Macular Edema

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)Diabetic Macular Edema (DME)
Novartis Pharmaceuticals 572
Not applicableEnded earlyNCT02510885
What this trial is testing

SD-OCT Angiography

Who this might be right for
Neovascular Age-related Macular DegenerationAge-related Macular DegenerationDiabetic Retinopathy+2 more
Duke University 39
Not applicableUnknownNCT00893724
What this trial is testing

Supplemental Adjuvants for Intracellular Nutrition and Treatment

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular Edema
Mid-Atlantic Retina Consultations, Inc. 60
Not applicableActive Not RecruitingNCT05476926
What this trial is testing

A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion+3 more
Hoffmann-La Roche 6,000
Not applicableActive Not RecruitingNCT06075147
What this trial is testing

The SPECTRUM Study: An Observational Study to Learn More About How Well Aflibercept 8 mg Works in Treating Visual Impairment Due to Neovascular Age-related Macular Degeneration or Diabetic Macula Edema

Who this might be right for
Visual ImpairmentNeovascular Age-related Macular Degeneration (nAMD)Diabetic Macula Edema (DME)
Bayer 2,500
Testing effectiveness (Phase 2)Study completedNCT02571972
What this trial is testing

Dorzolamide-timolol Drops With Injections to Treat AMD, RVO or DME.

Who this might be right for
Wet Macular DegenerationAge-related Macular DegenerationDiabetic Macular Edema+1 more
Wills Eye 14
Large-scale testing (Phase 3)Study completedNCT02698566
What this trial is testing

A Study in Patients With Neovascular Age Related Macular Degeneration or Macular Edema Secondary To Retinal Vein Occlusion to Evaluate Usability of the Ranibizumab (Lucentis®) Prefilled Syringe (PFS)

Who this might be right for
Macular Edema
Genentech, Inc. 35
Load More Results